Mario Cornacchione, DO
Geriatric Medicine · Allentown, PANPI 1194807503
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,421 of the $10,715 with a category attached, or 97.2%. Every reported general payment came from a single manufacturer, Biogen. Among geriatric medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $1190.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$11K
Across 181 payments — averaging $4352.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$402K
- Eisai Inc.$310K
- Genentech, Inc.$59K
- Boehringer Ingelheim$14K
- Merck$3K
- Boehringer Ingelheim RCV GmbH & Co KG$486
What the payments were for
- Consulting fees$10,42197%
- Travel & lodging$2092%
- Food & beverage$861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 9 | $10,715 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADUHELM$8,640
How this compares
$10,715 in reported general payments places this provider in the 95th percentile of 217 geriatric medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Donepezil Hcl | 79 | $502 |
| Memantine Hcl | 45 | $271 |
| Carvedilol | 42 | $190 |
| Lisinopril | 42 | $189 |
| Atorvastatin Calcium | 42 | $184 |
| Escitalopram Oxalate | 11 | $153 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Allentown
- Richard StefanacciPhiladelphia$146K
- James LinErie$73K
- Adele TowersPittsburgh$29K
- Michele ZaworaPhiladelphia$21K
- Daniel HaimowitzLevittown$15K
- Robert PearlsteinPlymouth Meeting$15K
- Seth CarterErie$14K
- Moushumi KunduHanover$12K
- Jason KarlawishPhiladelphia$11K
- Philip BenyoSugarloaf$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.